http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36253897

Outgoing Links

Predicate Object
contentType Multicenter Study|Journal Article|Research Support, Non-U.S. Gov't
endingPage e806
issn 2352-3018
issueIdentifier 12
pageRange e790-e806
publicationName The lancet. HIV
startingPage e790
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_876ad1ef60458dc29b64e3a5ed628ee9
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7b698dd385190fda9a543d700d94daa0
bibliographicCitation Sullivan AK, Saunders J, Desai M, Cartier A, Mitchell HD, Jaffer S, Ogaz D, Chiavenna C, Charlett A, Diamente V, Golombek R, Manavi K, Priestley C, Waters LJ, Milinkovic A, McOwan A, Estcourt C, Sabin CA, Rodger A, Gold D, Gazzard BG, McCormack S, Gill ON; Impact Study Group. HIV pre-exposure prophylaxis and its implementation in the PrEP Impact Trial in England: a pragmatic health technology assessment. Lancet HIV. 2023 Dec;10(12):e790–806. doi: 10.1016/s2352-3018(23)00256-4. PMID: 38040478.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f67fbb463fd04755957c6864db5a4827
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1bda02addfc42968ac20fdbed9bfb093
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed4c7b3499b289de1dce52f945aafa08
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e85fb6bf133fe10cfa00903de1ae6b0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f90b73e9a35de61287c1e0bf929c290c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63906169025007017f5b9de7e6d37551
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53f4cba5599a6ac4b2b563f209241d5b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_857cd464c721ae94a6ae97a0eb30f4d5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7702afa45223ab26c5251c6b173954e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9fc7129d612c3c2e2091df464726adef
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_88635e3cff6de24418c07600450855fb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e9e6243b5a1c1d33a37e544d1d39347
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e75c49f57ba7da3a71adbb9703d9e213
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9b383c79dec0161320c75c18d872a68
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5e4daa874da0ea0d9b081c44be4883d8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4412e7952e3b03c923e45f744412cdcd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5cd44b5de18a6b93e86d30325045d51
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5e88642b90c2b914a36b6b125da7774a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16de1c4eacb1fdb0b3161402ec869e71
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bdf471065ac9937884c9e0a961b849d8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d044a28625420fe236df8cba25c5ab82
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1eeee7fd4a383da142cba38f6836a601
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b87f2b2c5c6de3e140d4a96e35e6369
date 202312
identifier https://doi.org/10.1016/s2352-3018%2823%2900256-4
https://pubmed.ncbi.nlm.nih.gov/38040478
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43213
https://portal.issn.org/resource/ISSN/2352-3018
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title HIV pre-exposure prophylaxis and its implementation in the PrEP Impact Trial in England: a pragmatic health technology assessment
discusses http://id.nlm.nih.gov/mesh/M0028839
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D019380Q000627
http://id.nlm.nih.gov/mesh/D012749Q000453
http://id.nlm.nih.gov/mesh/D015658Q000453
http://id.nlm.nih.gov/mesh/D065129Q000379
http://id.nlm.nih.gov/mesh/D015658Q000517
http://id.nlm.nih.gov/mesh/D015658Q000175
http://id.nlm.nih.gov/mesh/D000072339
hasSubjectTerm http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D011446
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D018451
http://id.nlm.nih.gov/mesh/D004739Q000453
http://id.nlm.nih.gov/mesh/D013673
http://id.nlm.nih.gov/mesh/D008297

Showing number of triples: 1 to 58 of 58.